» Articles » PMID: 21095072

Impact of [11C]methionine Positron Emission Tomography for Target Definition of Glioblastoma Multiforme in Radiation Therapy Planning

Overview
Specialties Oncology
Radiology
Date 2010 Nov 25
PMID 21095072
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this work was to define the optimal margins for gadolinium-enhanced T(1)-weighted magnetic resonance imaging (Gd-MRI) and T(2)-weighted MRI (T(2)-MRI) for delineating target volumes in planning radiation therapy for postoperative patients with newly diagnosed glioblastoma multiforme (GBM) by comparison to carbon-11-labeled methionine positron emission tomography ([(11)C]MET-PET) findings.

Methods And Materials: Computed tomography (CT), MRI, and [(11)C]MET-PET were separately performed for radiation therapy planning for 32 patients newly diagnosed with GBM within 2 weeks after undergoing surgery. The extent of Gd-MRI (Gd-enhanced clinical target volume [CTV-Gd]) uptake and that of T(2)-MRI of the CTV (CTV-T(2)) were compared with the extent of [(11)C]MET-PET (CTV--[(11)C]MET-PET) uptake by using CT--MRI or CT--[(11)C]MET-PET fusion imaging. We defined CTV-Gd (x mm) and CTV-T(2) (x mm) as the x-mm margins (where x = 0, 2, 5, 10, and 20 mm) outside the CTV-Gd and the CTV-T(2), respectively. We evaluated the relationship between CTV-Gd (x mm) and CTV-- [(11)C]MET-PET and the relationship between CTV-T(2) (x mm) and CTV-- [(11)C]MET-PET.

Results: The sensitivity of CTV-Gd (20 mm) (86.4%) was significantly higher than that of the other CTV-Gd. The sensitivity of CTV-T(2) (20 mm) (96.4%) was significantly higher than that of the other CTV-T(2) (x = 0, 2, 5, 10 mm). The highest sensitivity and lowest specificity was found with CTV-T(2) (x = 20 mm).

Conclusions: It is necessary to use a margin of at least 2 cm for CTV-T(2) for the initial target planning of radiation therapy. However, there is a limit to this setting in defining the optimal margin for Gd-MRI and T(2)-MRI for the precise delineation of target volumes in radiation therapy planning for postoperative patients with GBM.

Citing Articles

Single-cell transcriptomic analysis of glioblastoma reveals pericytes contributing to the blood-brain-tumor barrier and tumor progression.

Li Y, Wu C, Long X, Wang X, Gao W, Deng K MedComm (2020). 2024; 5(12):e70014.

PMID: 39640361 PMC: 11617595. DOI: 10.1002/mco2.70014.


Recurrence Patterns after Radiotherapy for Glioblastoma with [(11)C]methionine Positron Emission Tomography-Guided Irradiation for Target Volume Optimization.

Debreczeni-Mate Z, Toro I, Simon M, Gal K, Barabas M, Sipos D Diagnostics (Basel). 2024; 14(9).

PMID: 38732378 PMC: 11083337. DOI: 10.3390/diagnostics14090964.


Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of C-methionine in IDH-mutant astrocytoma.

Yamamura T, Tamura K, Kobayashi D, Inaji M, Toyama Y, Wakimoto H J Neurooncol. 2024; 168(2):355-365.

PMID: 38557927 DOI: 10.1007/s11060-024-04661-y.


Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [C] methionine PET and T1c-w MRI.

Shahzadi I, Seidlitz A, Beuthien-Baumann B, Zwanenburg A, Platzek I, Kotzerke J Sci Rep. 2024; 14(1):4576.

PMID: 38403632 PMC: 10894870. DOI: 10.1038/s41598-024-55092-8.


A Systematic Review of Amino Acid PET Imaging in Adult-Type High-Grade Glioma Surgery: A Neurosurgeon's Perspective.

De Marco R, Pesaresi A, Bianconi A, Zotta M, Deandreis D, Morana G Cancers (Basel). 2023; 15(1).

PMID: 36612085 PMC: 9817716. DOI: 10.3390/cancers15010090.